Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 501–600 of 1,000
The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma
Min, C. (2011) · The Korean Journal of Hematology · doi:10.5045/kjh.2011.46.2.80 · Cited by 61
Sonntag, K., Eckert, F., Welker, C., Müller, H., Müller, F., Zips, D., Sipos, B., Klein, R., Blank, G., Feuchtinger, T. F., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.006 · Cited by 59
The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring
Huang, C., & Ogawa, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072542 · Cited by 63
Nanotechnology in Drug Delivery for Liver Fibrosis
Gu, L., Zhang, F., Wu, J., & Zhuge, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.804396 · Cited by 73
“Th1 cells secrete IFN-γ to reduce liver fibrosis, while Th2 cells can promote fibrosis by activating HSCs via cytokine release (Wynn, 2004).”
BackgroundProgressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations
Devane, J., Ott, E. B., Olinger, E. G., Epting, D., Decker, E., Friedrich, A., Bachmann, N., Renschler, G., Eisenberger, T., Briem‐Richter, A., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.03.015 · Cited by 62
Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis
Lloyd, S. M., & He, Y. (2024) · Cells · doi:10.3390/cells13050438 · Cited by 61
“Even though fibrosis contributes to up to 45% of deaths in industrialized areas, there remains a limited understanding of how fibrosis develops over time and how the process could be reversed and resolved [2,6].”
BackgroundGammaherpesviruses and Pulmonary Fibrosis: Evidence From Humans, Horses, and Rodents
Williams, K. J. (2014) · Veterinary Pathology · doi:10.1177/0300985814521838 · Cited by 61
Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development
Schiechl, G., Hermann, F. J., Gomez, M. R., Kutzi, S., Schmidbauer, K., Talke, Y., Neumayer, S., Goebel, N., Renner, K., Brühl, H., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13764 · Cited by 63
Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview
Wen, W. X., Lee, S. Y., Siang, R., & Koh, R. Y. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0547-2 · Cited by 63
BRD4 inhibition for the treatment of pathological organ fibrosis
Stratton, M. S., Haldar, S. M., & McKinsey, T. A. (2017) · F1000Research · doi:10.12688/f1000research.11339.1 · Cited by 58
Guo, X., Li, T., Xu, Y. Y., Xu, X., Zhu, Z., Zhang, Y., Xu, J., Xu, K., Cheng, H., Zhang, X. Z., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.802066 · Cited by 59
Masola, V., Zaza, G., Bellin, G., Dall’Olmo, L., Granata, S., Vischini, G., Secchi, M. F., Lupo, A., Gambaro, G., & Onisto, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700597r · Cited by 59
Regulatory T cells in inflammatory skin disease: from mice to humans
Kalekar, L. A., & Rosenblum, M. D. (2019) · International Immunology · doi:10.1093/intimm/dxz020 · Cited by 65
Mechanisms Underlying Helminth- Induced Th2 Polarization: Default, Negative or Positive Pathways?
Jankovic, D. L., Steinfelder, S., Kullberg, M. C., & Sher, A. (2005) · KARGER eBooks · doi:10.1159/000088881 · Cited by 58
A role for MCP-1/CCR2 in interstitial lung disease in children
Hartl, D., Griese, M., Nicolaï, T., Zissel, G., Prell, C., Reinhardt, D., Schendel, D. J., & Krauss‐Etschmann, S. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-93 · Cited by 66
“In addition to the MCP-1/CCR2 axis, Th2 cytokines seem to mediate pulmonary fibrosis [ 19-22 ].”
BackgroundRegulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
Ramalingam, T. R., Pesce, J. T., Mentink-Kane, M. M., Madala, S., Cheever, A. W., Comeau, M. R., Ziegler, S. F., & Wynn, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900181 · Cited by 57
“Instead, changes in the host immune response regulate the severity of the disease, with highly polarized Th1/Th17 responses causing significant acute morbidity and mortality characterized by the development of hepatotoxicity and endotoxemia (53–55) and highly polarized Th2 responses triggering chronic morbidity and mo…”
BackgroundSelf-citationMoriya, C., Jinnin, M., Yamane, K., Maruo, K., Muchemwa, F. C., Igata, T., Makino, T., Fukushima, S., & Ihn, H. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.361 · Cited by 59
Lin, M.-S., Sun, Y., Chiu, W., Hung, C., Chang, C., Shie, F., Tsai, S., Lin, J., Hung, K.-S., & Lee, Y. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1768 · Cited by 63
“Wynn (2004), using cDNA microarrays, found that a large number of RANTES-responsive genes in cultured neurons appeared to be involved in neuronal survival and differentiation.”
Arsenic Trioxide Prevents Murine Sclerodermatous Graft-versus-Host Disease
Kavian, N., Marut, W., Servettaz, A., Laude, H., Nicco, C., Chéreau, C., Weill, B. J., & Batteux, F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103538 · Cited by 57
Iacob, S., Cicinnati, V. R., Dechêne, A., Lindemann, M., Heinemann, F. M., Rebmann, V., Ferenčík, S., Sotiropoulos, G. C., Popescu, I., Horn, P. A., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02810.x · Cited by 59
Checa, J., & Aran, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239317 · Cited by 61
The clinical and immunologic features of pulmonary fibrosis in sarcoidosis
Patterson, K. C., Hogarth, K. D., Husain, A. N., Sperling, A. I., & Niewold, T. B. (2012) · Translational research · doi:10.1016/j.trsl.2012.03.005 · Cited by 62
Interleukin-13 as an important cytokine: A review on its roles in some human diseases
Seyfizadeh, N., Seyfizadeh, N., Gharibi, T., & Babaloo, Z. (2015) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.62.2015.4.2 · Cited by 63
“It involves both directly and indirectly in the fi broblast activation and stimulation of TGF-β, respectively [107].”
BackgroundEnhanced protection from fibrosis and inflammation in the combined absence of IL‐13 and IFN‐γ
Ramalingam, T. R., Gieseck, R. L., Acciani, T. H., M Hart, K., Cheever, A. W., Mentink‐Kane, M. M., Vannella, K. M., & Wynn, T. A. (2016) · The Journal of Pathology · doi:10.1002/path.4733 · Cited by 55
Self-citationJiao, H., Zhang, T., Fan, J., & Xiao, R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00885 · Cited by 65
“T-lymphocytes are believed to promote fibrosis by secreting cytokines such as IL-4, IL-5, IL-6, IL-10, and IL-13 to stimulate the synthesis of collagen by human fibroblasts (Wynn, 2004).”
BackgroundTowards a unified approach in the modeling of fibrosis: A review with research perspectives
Amar, M. B., & Bianca, C. (2016) · Physics of Life Reviews · doi:10.1016/j.plrev.2016.03.005 · Cited by 63
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
Malaviya, R., Kipen, H. M., Businaro, R., Laskin, J. D., & Laskin, D. L. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115272 · Cited by 59
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment
Pehrsson, M., Mortensen, J. H., Manon‐Jensen, T., Bay‐Jensen, A., Karsdal, M. A., & Davies, M. J. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1962711 · Cited by 58
Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer
Kopchick, J. J., Basu, R., Berryman, D. E., Jørgensen, J. O. L., Johannsson, G., & Puri, V. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00702-6 · Cited by 61
Epa, A. P., Thatcher, T. H., Pollock, S. J., Wahl, L. A., Lyda, E., Kottmann, R. M., Phipps, R. P., & Sime, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135266 · Cited by 61
Naito, K., Anzai, T., Sugano, Y., Maekawa, Y., Kohno, T., Yoshikawa, T., Matsuno, K., & Ogawa, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5691 · Cited by 69
Sampson, N., Berger, P., & Zenzmaier, C. (2014) · BioMed Research International · doi:10.1155/2014/131737 · Cited by 60
Joshi, A., Raymond, T., Coelho, A. L., Kunkel, S. L., & Hogaboam, C. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007689 · Cited by 59
Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis
Madan, B., Patel, M. B., Zhang, J., Bunte, R. M., Rudemiller, N. P., Griffiths, R., Virshup, D. M., & Crowley, S. D. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.017 · Cited by 58
“As proinflammatory cytokines produced in the kidney by intrinsic and/or infiltrating immune cells are key instigators of fibrosis, we measured the expression of several profibrotic cytokines in the kidneys from both vehicle- and PORCN inhibitor–treated animals (Figure 6).(4,16,17) Indeed, there was a marked upregulati…”
BackgroundPeng, Y., Yang, T., Huang, K., Shen, L., Tao, Y., & Liu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00762 · Cited by 59
“It is accepted commonly that T cells, B cells and NK T cells play dual roles in controlling HSC activation and liver fibrosis by produce both anti-fibrotic and pro-fibrotic cytokines (Wynn, 2004; Holt et al., 2006; Park et al., 2009).”
BackgroundMu, R., de Souza, S. C., Liao, Z., Dong, L., & Wang, C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114298 · Cited by 59
Liu, X., Xu, M., Fan, S.-T., Wu, Z., Li, J., Yang, X., Wang, Y., Xu, J. Y., & Zhang, Z. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.486 · Cited by 53
Combined Tlr2 and Tlr4 Deficiency Increases Radiation-Induced Pulmonary Fibrosis in Mice
Paun, A., Fox, J., Balloy, V., Chignard, M., Qureshi, S. T., & Haston, C. K. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.065 · Cited by 57
Liang, M., Lv, J., Zou, L., Yang, W., Xiong, Y., Chen, X., Guan, M., He, R., & Zou, H. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.145 · Cited by 57
SHIP-Deficient Mice Develop Spontaneous Intestinal Inflammation and Arginase-Dependent Fibrosis
McLarren, K. W., Cole, A. E., Weisser, S. B., Voglmaier, N., Conlin, V. S., Jacobson, K., Popescu, O., Boucher, J., & Sly, L. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.018 · Cited by 57
Dysregulated Macrophages Are Present in Bleomycin‐Induced Murine Laryngotracheal Stenosis
Hillel, A. T., Samad, I., Ma, G., Ding, D., Sadtler, K., Powell, J. D., Lane, A. P., & Horton, M. R. (2015) · Otolaryngology · doi:10.1177/0194599815589106 · Cited by 56
IgG4-Related Autoimmune Diseases
Kleger, A., Seufferlein, T. T. W., Wagner, M., Tannapfel, A., Hoffmann, T. K., & Mayerle, J. V. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0128 · Cited by 56
The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
Planté-Bordeneuve, T., Pilette, C., & Froidure, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631235 · Cited by 67
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 68
Medsger, T. A., Ivanco, D. E., Kardava, L., Morel, P. A., Lucas, M. R., & Fuschiotti, P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30489 · Cited by 53
Sun, H., Tian, J., Xian, W., Xie, T., & Yang, X. (2015) · Inflammation · doi:10.1007/s10753-015-0151-z · Cited by 57
Saw, V. P. J., Offiah, I., Dart, R., GALATOWICZ, G. E., Dart, J. K. G., Daniels, J. T., & Calder, V. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090579 · Cited by 53
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 53
Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling.
Delire, B., Lebrun, V., Selvais, C., Henriet, P., Bertrand, A., Horsmans, Y., & Leclercq, I. A. (2016) · Aging · doi:10.18632/aging.101124 · Cited by 49
Cytokines in the immunopathology of systemic sclerosis
Raja, J., & Denton, C. P. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0511-7 · Cited by 60
Grove, L. M., Mohan, M. L., Abraham, S., Scheraga, R. G., Southern, B. D., Crish, J. F., Naga Prasad, S. V., & Olman, M. A. (2019) · Science Signaling · doi:10.1126/scisignal.aau1533 · Cited by 51
The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Xu, Y., Lan, P., & Wang, T. (2023) · Medicina · doi:10.3390/medicina59111984 · Cited by 68
“Overexpression of IL-9 in vivo can cause a large amount of collagen and laminin to accumulate in the bronchus, thus producing a pro-fibrotic effect [101].”
BackgroundQuantitative Analysis of Amino Acid Oxidation Markers by Tandem Mass Spectrometry
Vivekanandan-Giri, A., Byun, J., & Pennathur, S. (2011) · Methods in Enzymology · doi:10.1016/b978-0-12-385928-0.00005-5 · Cited by 52
“Indeed, fibrosis is a major cause of organ failure and death accounting for roughly 45% of mortality in the United States population (Wynn, 2004).”
BackgroundThe role of macrophage IL‐10/innate IFN interplay during virus‐induced asthma
Zdrenghea, M., Makrinioti, H., Mureșan, A., Johnston, S. L., & Stanciu, L. A. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1817 · Cited by 60
Role of IL-13 in systemic sclerosis
Fuschiotti, P. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.030 · Cited by 60
Characterization of CD45RO+ memory T lymphocytes in keloid disease
Chen, Z., Zhou, L., Won, T., Gao, Z., Wu, X., & Lu, L. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16173 · Cited by 59
Zhu, Y., Chai, Y., Xiao, G., Liu, Y., Xie, X., Xiao, W. L., Zhou, P., Ma, W., Zhang, C., & Li, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1040350 · Cited by 55
“Fibrosis may be caused by normal healing or by pathological deposition of fibrous connective tissue (Zhang and Zhang, 2020), which occurs in various organs such as lung, heart, kidney, peritoneum, and is responsible for approximately 45% of all deaths in western developed countries (Wynn, 2004).”
BackgroundAntioxidant therapy against TGF ‐β/ SMAD pathway involved in organ fibrosis
Ghafouri‐Fard, S., Askari, A., Shoorei, H., Seify, M., Koohestanidehaghi, Y., Hussen, B. M., Taheri, M. N., & Samsami, M. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18052 · Cited by 62
Almeida, I., Silva, S. V., Fonseca, A. R., Silva, I., Vasconcelos, C., & Lima, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8505-8 · Cited by 58
A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials
Sanchez, V. C., Weston, P. J., Yan, A., Hurt, R. H., & Kane, A. B. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-17 · Cited by 56
Raza, S., Barnett, M. W., Barnett-Itzhaki, Z., Amit, I., Hume, D. A., & Freeman, T. C. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.6hi0313-169r · Cited by 51
Physiological potential of cytokines and liver damages
Mannaa, F. A. E., & Abdel-Wahhab, K. G. (2016) · Hepatoma Research · doi:10.20517/2394-5079.2015.58 · Cited by 56
Hughes, F. M., Sexton, S. J., Jin, H., Govada, V., & Purves, J. T. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00128.2017 · Cited by 54
Cui, X., Mino, T., Yoshinaga, M., Nakatsuka, Y., Hia, F., Yamasoba, D., Tsujimura, T., Tomonaga, K., Suzuki, Y., Uehata, T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701211 · Cited by 52
Gavrović-Jankulović, M. Đ., Poulsen, K., Brckalo, T., Bobic, S., Lindner, B., & Petersen, A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.033 · Cited by 51
Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis
Peng, H., Xian, D., Liu, J., Pan, S., Tang, R., & Zhong, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/8148272 · Cited by 56
“…chemokines (CXCL9-11) attract Th1/Th17 cells to the vascular in fl am-matory site [48]; beyond that, some proin fl ammatory factors from M1 (IL-12, IL-23, IL-27, etc.) encourage Th1/Th17 differentiation and Th1/Th17-derived factor secretion (IL-17A, IFN-γ , IL-17F, IL-21, and IL-26) [49, 50].”
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery
Kolanko, E., Cargnoni, A., Papait, A., Silini, A. R., Czekaj, P., & Parolini, O. (2024) · European Respiratory Review · doi:10.1183/16000617.0127-2023 · Cited by 56
Liu, Y.-Y., Cai, W., Yang, H.-Z., Cui, B., Chen, Z.-R., Liu, H.-Z., Yan, J., Jin, W., Yan, H.-M., Xin, B.-M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7349 · Cited by 50
“It has been found that fibrogenesis is strongly linked with the development of a Th2 response (23).”
BackgroundGhatak, S., Markwald, R. R., Hascall, V. C., Dowling, W., Lottes, R. G., Baatz, J. E., Beeson, G., Beeson, C., Perrella, M. A., Thannickal, V. J., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752451 · Cited by 56
Kuehl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 50
“It is estimated that fibrotic disorders such as idiopathic pulmonary fibrosis (IPF), chronic kidney disease (CKD), liver cirrhosis, cardiac fibrosis and systemic sclerosis (SSc, scleroderma) account for 45 percent of deaths in the developing world [8].”
BackgroundDecorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice
Zen, A. A. H., Caligiuri, G., Sainz, J., Lemitre, M., Demerens, C., & Lafont, A. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.08.023 · Cited by 53
Chen, G., Deutsch, G. H., Schulert, G. S., Zheng, H., Jang, S., Trapnell, B. C., Lee, P. Y., Macaubas, C., Ho, K., Schneider, C., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42099 · Cited by 52
Stem cell therapy in pulmonary fibrosis
Τzouvelekis, Α., Antoniadis, A., & Bouros, D. E. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328348744f · Cited by 53
Duval, F., Moreno-Cuevas, J. E., González‐Garza, M. T., Maldonado‐Bernal, C., & Cruz‐Vega, D. E. (2015) · International Journal of Inflammation · doi:10.1155/2015/943497 · Cited by 54
Ray, S., De Salvo, C., & Pizarro, T. T. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000119 · Cited by 49
Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts
Shiwen, X., Liu, S., Eastwood, M., Sonnylal, S., Denton, C. P., Abraham, D., & Leask, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007438 · Cited by 59
Induction of Type 2 Responses by Schistosome Worms during Prepatent Infection
Fraga, L. A. D. O., Torrero, M. N., Tocheva, A. S., Mitre, E. E. S., & Davies, S. J. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/649841 · Cited by 49
Peng, X., Moore, M. W., Peng, H., Sun, H., Gan, Y., Homer, R. J., & Herzog, E. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00080 · Cited by 49
“This paradigm renders TGF-β1-targeted therapies particularly attractive for the treatment of fibrotic lung disorders however given its central role in the regulation of cellular survival, proliferation, ECM maintenance, tumorigenesis, and immune regulation, direct inhibition of TGF-β1 might have undesired effects on t…”
BackgroundBersini, S., Gilardi, M., Mora, M., Krol, S., Arrigoni, C., Candrian, C., Zanotti, S., & Moretti, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.02.009 · Cited by 60
The role of adipokines in systemic sclerosis: a missing link?
Żółkiewicz, J., Stochmal, A., & Rudnicka, L. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01893-1 · Cited by 53
Tian, X., Yang, L., Liu, X., Gao, S., & Sun, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109481 · Cited by 53
Cardiovascular diseases in survivors of childhood cancer
Bansal, N., Blanco, J. G., Sharma, U. C., Pokharel, S., Shisler, S., & Lipshultz, S. E. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09859-w · Cited by 50
Idiopathic Pulmonary Fibrosis: New Concepts in Pathogenesis and Implications for Drug Therapy
Horowitz, J. C., & Thannickal, V. J. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605050-00004 · Cited by 52
“[65,75] Myofibroblasts are likely disease (recently reviewed by Wynn[142]).”
Zhang, X.-W., Mi, S., Li, Z., Zhou, J.-C., Xie, J., Hua, F., Li, K., Cui, B., Lv, X.-X., Yu, J.-J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14266 · Cited by 48
Morphological changes of macrophages and their potential contribution to tendon healing
Yang, Q., Zhang, L., Zhou, Y. L., & Tang, J. B. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112145 · Cited by 47
Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
Nulali, J., Zhan, M., Zhang, K., Tu, P., Liu, Y., & Song, H. (2022) · Biomolecules · doi:10.3390/biom12111674 · Cited by 57
Pan, K., Li, Q., Guo, Z., & Li, Z. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108760 · Cited by 56
Dasgupta, P., & Keegan, A. D. (2012) · Journal of Innate Immunity · doi:10.1159/000336025 · Cited by 55
Mahrouf-Yorgov, M., de l'Hortet, A. C., Cosson, C., Slama, A., Abdoun, E., Guidotti, J.-E., Fromenty, B., Mitchell, C., & Gilgenkrantz, H. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1146 · Cited by 48
A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis
Li, Q., Zheng, M., Liu, Y., Sun, W., Shi, J., Ni, J., & Wang, Q. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.023 · Cited by 51
“In contrast, activated M2 macrophages produce anti-inflammatory molecules (Mantovani et al., 2004; Wynn, 2004; Wang et al., 2007), such as IL-10, and contain scavenger mannose and galactose receptors CD163 and CD206.”
BackgroundSong, G., Zhang, Y., Yu, S., Lv, W., Guan, Z., Sun, M., & Wang, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6444 · Cited by 48
“The main Th2 cytokines—interleukin (IL)‐4, IL‐5, and IL‐13—are pivotal proinflammatory cytokines in asthma that contribute to airway inflammation and remodeling (Richter et al., 2001; Wynn, 2004).”
BackgroundZhang, M., Haughey, M., Wang, N.-Y., Blease, K., Kapoun, A. M., Couto, S., Belka, I., Hoey, T., Groza, M., Hartke, J., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229445 · Cited by 48
Regulatory T cells are a double-edged sword in pulmonary fibrosis
Wang, F., Xia, H., & Yao, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106443 · Cited by 57
Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues
Dooling, L. J., Saini, K., Anlaş, A. A., & Discher, D. E. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.06.006 · Cited by 46
Spagnolo, P., Tonelli, R., Samarelli, A. V., Castelli, G., Cocconcelli, E., Petrarulo, S., Cerri, S., Bernardinello, N., Clini, E. M., Saetta, M. P., et al. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2114897 · Cited by 45
Becker, L., Lu, C., Montes-Mojarro, I. A., Layland, S. L., Khalil, S., Nsair, A., Duffy, G. P., Fend, F., Marzi, J., & Schenke‐Layland, K. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.016 · Cited by 50
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
Chizzolini, C. (2007) · Annals of Medicine · doi:10.1080/07853890601098152 · Cited by 58
NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents
Babalola, O., Mamalis, A., Lev-Tov, H., & Jagdeo, J. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-013-1416-8 · Cited by 47
Leukocytes: The Double‐Edged Sword in Fibrosis
Kryczka, J. M., & Boncela, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/652035 · Cited by 51
Burton, M. J., Ramadhani, A. M., Weiss, H. A., Hu, V. H., Massae, P., Burr, S. E., Shangali, W., Holland, M. J., Mabey, D. C. W., & Bailey, R. L. (2011) · Infection and Immunity · doi:10.1128/iai.05718-11 · Cited by 55
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.